César Picado

Q: What Schools Are Affiliated With César Picado

César Picado is affiliated with the following schools: University of California, Berkeley, Stanford University, University of Barcelona

César Picado's AcademicInfluence.com Rankings

César Picado

Computer Science

#9854

World Rank

#10337

Historical Rank

Machine Learning

#4423

World Rank

#4473

Historical Rank

Artificial Intelligence

#4778

World Rank

#4841

Historical Rank

Database

#6804

World Rank

#7043

Historical Rank

computer-science Degrees

Download Badge

Computer Science

César Picado's Degrees

PhD Computer Science Stanford University
Masters Computer Science Stanford University
Bachelors Computer Science Stanford University

Similar Degrees You Can Earn

Why Is César Picado Influential?

(Suggest an Edit or Addition)

(See a Problem?)

César Picado's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity (2007) (390)
Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial. (2002) (323)
Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. (1999) (234)
Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. (1991) (231)
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial (2003) (210)
Expression of glucocorticoid receptor α- and β-isoforms in human cells and tissues (2002) (202)
Nasal polyposis and its impact on quality of life: comparison between the effects of medical and surgical treatments (2005) (188)
Lipid transfer protein syndrome: clinical pattern, cofactor effect and profile of molecular sensitization to plant‐foods and pollens (2012) (177)
Validation of the Spanish Version of the Asthma Control Test (ACT) (2007) (172)
[Pulmonary manifestations of inflammatory bowel disease]. (2005) (171)
Furthering the understanding of olfaction, prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study) (2012) (171)
Transforming Growth Factor-β1 Gene Polymorphisms Are Associated with Disease Progression in Idiopathic Pulmonary Fibrosis (2003) (156)
Rupatadine in allergic rhinitis and chronic urticaria (2008) (151)
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma (2003) (149)
Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients. (1992) (144)
Expression of glucocorticoid receptor alpha- and beta-isoforms in human cells and tissues. (2002) (120)
Dietary micronutrients/antioxidants and their relationship with bronchial asthma severity (2001) (120)
Expression of the human glucocorticoid receptor alpha and beta isoforms in human respiratory epithelial cells and their regulation by dexamethasone. (2001) (115)
Reduced expression of COXs and production of prostaglandin E(2) in patients with nasal polyps with or without aspirin-intolerant asthma. (2011) (114)
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma (2002) (112)
Prevention of further bone mass loss by nasal calcitonin in patients on long term glucocorticoid therapy for asthma: a two year follow up study. (1994) (110)
Diffuse alveolar hemorrhage in allogeneic bone marrow transplantation. A postmortem study. (1995) (108)
Barcelona Smell Test - 24 (BAST-24): validation and smell characteristics in the healthy Spanish population. (2006) (107)
Effects of Omalizumab in Non-Atopic Asthma: Results from a Spanish Multicenter Registry (2013) (107)
A Short Course of Oral Prednisone Followed by Intranasal Budesonide Is an Effective Treatment of Severe Nasal Polyps (2006) (105)
Treatment of steroid-induced osteopenia with calcitonin in corticosteroid-dependent asthma. A one-year follow-up study. (1990) (104)
Bone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two years (2001) (103)
Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps (1995) (99)
Mucin genes have different expression patterns in healthy and diseased upper airway mucosa (2006) (99)
Intranasal challenge with aspirin in the diagnosis of aspirin intolerant asthma: evaluation of nasal response by acoustic rhinometry (2000) (98)
Efficacy of omalizumab in the treatment of nasal polyps (2010) (97)
Aspirin-intolerance as a precipitating factor of life-threatening attacks of asthma requiring mechanical ventilation. (1989) (97)
Omalizumab Therapy in Severe Asthma: Experience from the Spanish Registry—Some New Approaches (2012) (89)
Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. (2005) (88)
How many manoeuvres should be done to measure maximal inspiratory mouth pressure in patients with chronic airflow obstruction? (1989) (87)
Glucocorticoid receptors in human airways (2004) (87)
Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation (2009) (79)
Alexithymia: a relevant psychological variable in near-fatal asthma (2006) (78)
Transforming growth factor-beta1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis. (2003) (75)
Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM–CSF and inhibition by dexamethasone (1994) (73)
Cyclooxygenase 1 and cyclooxygenase 2 expression is abnormally regulated in human nasal polyps. (2002) (70)
Alpha and beta glucocorticoid receptors: Relevance in airway diseases (2007) (70)
Glucocorticoid Receptor Isoforms α and β in in Vitro Cytokine-induced Glucocorticoid Insensitivity (2004) (69)
Losartan attenuates bleomycin induced lung fibrosis by increasing prostaglandin E2 synthesis (2006) (69)
United airways again: high prevalence of rhinosinusitis and nasal polyps in bronchiectasis (2009) (68)
Mechanisms of Anaphylaxis Beyond IgE. (2016) (68)
Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease. (2013) (66)
Respiratory and skeletal muscle function in steroid-dependent bronchial asthma. (1990) (65)
Asthma outcomes improve with continuous positive airway pressure for obstructive sleep apnea (2016) (64)
Effects of a fish oil enriched diet on aspirin intolerant asthmatic patients: a pilot study. (1988) (64)
Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study (2004) (63)
Dynamics of COX-2 in nasal mucosa and nasal polyps from aspirin-tolerant and aspirin-intolerant patients with asthma. (2004) (63)
Comparative study of the effects of different glucocorticosteroids on eosinophil survival primed by cultured epithelial cell supernatants obtained from nasal mucosa and nasal polyps. (1995) (63)
Corticosteroid-Induced Bone Loss (1996) (63)
Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis (2017) (62)
Rupatadine: pharmacological profile and its use in the treatment of allergic disorders (2006) (60)
Prevalence of uncontrolled severe persistent asthma in pneumology and allergy hospital units in Spain. (2011) (58)
Effect of topical anti-inflammatory drugs on epithelial cell-induced eosinophil survival and GM-CSF secretion. (1997) (57)
Effect of three different bronchodilators during an exacerbation of chronic obstructive pulmonary disease. (1988) (56)
Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino‐nasal polyposis (2014) (56)
The impact of asthma and aspirin sensitivity on quality of life of patients with nasal polyposis (2005) (56)
United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient’s quality of life (2009) (55)
Oral and inhalation provocation tests for the diagnosis of aspirin‐induced asthma (2001) (55)
Cyclooxygenase-2 is up-regulated in lung parenchyma of chronic obstructive pulmonary disease and down-regulated in idiopathic pulmonary fibrosis. (2004) (54)
Persistent asthma has an accumulative impact on the loss of smell in patients with nasal polyposis. (2011) (54)
Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids (2008) (53)
Near-fatal asthma related to menstruation. (2004) (53)
Expression of the glucocorticoid receptor alpha and beta isoforms in human nasal mucosa and polyp epithelial cells. (2003) (52)
Clinical characteristics in 545 patients with severe asthma on biological treatment during the COVID-19 outbreak (2020) (51)
Bone mineral density in asthmatic patients treated with inhaled corticosteroids: a case-control study. (1997) (51)
Role of bronchoalveolar lavage in the diagnosis of fat embolism syndrome. (1995) (50)
Validation of the Spanish version of the Asthma Control Questionnaire. (2008) (49)
Aspirin‐intolerant asthma: role of cyclo‐oxygenase enzymes (2002) (49)
Lipid and protein metabolism in asthma. Effects of diet and corticosteroid therapy (1999) (49)
Pulmonary involvement in primary biliary cirrhosis. (1981) (48)
Endothelin-1 induces GM-CSF, IL-6 and IL-8 but not G-CSF release from a human bronchial epithelial cell line (BEAS-2B) (1996) (48)
Assessment of nasal obstruction: correlation between subjective and objective techniques. (2013) (47)
Mechanical ventilation in severe exacerbation of asthma. Study of 26 cases with six deaths. (1983) (47)
Ventilatory control in diabetes mellitus. (1985) (46)
[Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 Questionnaire]. (2008) (46)
E‐prostanoid 2 receptors dampen mast cell degranulation via cAMP/PKA‐mediated suppression of IgE‐dependent signaling (2012) (46)
Montelukast or salmeterol combined with an inhaled steroid in adult asthma: design and rationale of a randomized, double-blind comparative study (the IMPACT Investigation of Montelukast as a Partner Agent for Complementary Therapy-trial). (2000) (46)
Role of Art v 3 in pollinosis of patients allergic to Pru p 3. (2014) (45)
Nuclear factor‐κB activity is down‐regulated in nasal polyps from aspirin‐sensitive asthmatics (2003) (44)
Upregulation of COX-1 and COX-2 in nasal polyps in cystic fibrosis (2006) (43)
Classification of severe asthma exacerbations: a proposal. (1996) (43)
CT of Pulmonary Epithelioid Hemangioendothelioma (1994) (43)
Expression of glucocorticoid receptors α and β in steroid sensitive and steroid insensitive interstitial lung diseases (2004) (42)
Aspirin intolerance and nasal polyposis (2002) (41)
Effects of topical anti‐inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium (1997) (40)
Effect of desloratadine on epithelial cell granulocyte‐macrophage colony‐stimulating factor secretion and eosinophil survival (2006) (39)
Predisposing factors to death after recovery from a life-threatening asthmatic attack. (1989) (39)
Mechanisms of aspirin sensitivity (2006) (39)
Low E-prostanoid 2 receptor levels and deficient induction of the IL-1β/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. (2016) (38)
Patients with chronic glucocorticoid treatment develop changes in muscle glycogen metabolism (1993) (38)
The Loss of Smell in Persistent Allergic Rhinitis Is Improved by Levocetirizine due to Reduction of Nasal Inflammation but Not Nasal Congestion (the CIRANO Study) (2012) (38)
Asthma and Obesity: Two Diseases on the Rise and Bridged by Inflammation (2021) (37)
Duration of the efficacy of omalizumab after treatment discontinuation in ‘real life’ severe asthma (2017) (37)
El tratamiento según la guía de la Global Initiative for Asthma (GINA) reduce la morbimortalidad de los pacientes con asma de riesgo vital (2008) (37)
The impact of bronchiectasis associated to sinonasal disease on quality of life. (2006) (36)
Montelukast reduces eosinophilic inflammation by inhibiting both epithelial cell cytokine secretion (GM-CSF, IL-6, IL-8) and eosinophil survival. (2010) (36)
The Impact of Atopy, Sinus Opacification, and Nasal Patency on Quality of Life in Patients with Severe Nasal Polyposis (2006) (36)
Angiotensinogen gene G-6A polymorphism influences idiopathic pulmonary fibrosis disease progression (2008) (35)
Glucocorticoid receptor isoforms alpha and beta in in vitro cytokine-induced glucocorticoid insensitivity. (2004) (35)
Distinct transcriptome profiles differentiate nonsteroidal anti-inflammatory drug-dependent from nonsteroidal anti-inflammatory drug-independent food-induced anaphylaxis. (2016) (35)
Lung Myofibroblasts Are Characterized by Down-Regulated Cyclooxygenase-2 and Its Main Metabolite, Prostaglandin E2 (2013) (34)
Corticosteroid therapy increases membrane‐tethered while decreases secreted mucin expression in nasal polyps (2008) (34)
Descubriendo el asma de origen alérgico a través del ratón. Un repaso a la patogenia de los modelos de asma alérgica en el ratón y su similitud con el asma alérgica humana (2005) (32)
Effect of budesonide and nedocromil sodium on IL-6 and IL-8 release from human nasal mucosa and polyp epithelial cells. (2001) (32)
Genetic association study in nasal polyposis. (2012) (32)
The PGE2-EP2-mast cell axis: an antiasthma mechanism. (2015) (31)
Role of Cyclooxygenase-2 on Intermittent Hypoxia-Induced Lung Tumor Malignancy in a Mouse Model of Sleep Apnea (2017) (31)
The importance of smell in patients with bronchiectasis. (2011) (31)
Prostaglandin E2 receptors in asthma and in chronic rhinosinusitis/nasal polyps with and without aspirin hypersensitivity (2014) (31)
CD84 Negatively Regulates IgE High-Affinity Receptor Signaling in Human Mast Cells (2011) (31)
Importance of glucocorticoid receptors in upper and lower airways. (2010) (30)
Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. (1991) (29)
Spontaneous pneumothorax in cryptogenic fibrosing alveolitis. (1985) (29)
Response of the nose to exercise in healthy subjects and in patients with rhinitis and asthma. (1994) (28)
NSAID‐sensitive patients tolerate rofecoxib (2002) (28)
Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain (2016) (28)
Activity of the cyclooxygenase 2-prostaglandin-E prostanoid receptor pathway in mice exposed to house dust mite aeroallergens, and impact of exogenous prostaglandin E2 (2009) (28)
Mucus hypersecretion in asthma is associated with rhinosinusitis, polyps and exacerbations. (2018) (28)
Bronchoalveolar lavage analysis with anti-T6 monoclonal antibody in the evaluation of diffuse lung diseases. (1989) (27)
Rinitis y asma: una vía respiratoria, una enfermedad (2005) (27)
[Rhinitis and asthma: one airway, one disease]. (2005) (27)
Glucocorticoid Receptor in Human Respiratory Epithelial Cells (2009) (27)
Nasal and bronchial inflammation after nasal allergen challenge: assessment using noninvasive methods. (2012) (27)
Prostaglandin E2 Prevents Hyperosmolar-Induced Human Mast Cell Activation through Prostanoid Receptors EP2 and EP4 (2014) (26)
In vivo release of 15-HETE and other arachidonic acid metabolites in nasal secretions during early allergic reactions. (1991) (26)
Bronchial adenocarcinoma presenting as a lingual tonsillar metastasis. (1987) (26)
Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite‐induced airway hyperresponsiveness and inflammation by restraining mast cells’ activity (2015) (26)
Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps (2015) (26)
Low prostaglandin E2 and cyclooxygenase expression in nasal mucosa fibroblasts of aspirin‐intolerant asthmatics (2013) (25)
Subcutaneous Prostaglandin E2 Restrains Airway Mast Cell Activity in vivo and Reduces Lung Eosinophilia and Th2 Cytokine Overproduction in House Dust Mite-Sensitive Mice (2009) (25)
In vitro release of arachidonic acid metabolites, glutathione peroxidase, and oxygen-free radicals from platelets of asthmatic patients with and without aspirin intolerance. (1995) (25)
Nonsteroidal anti‐inflammatory drugs enhance IgE‐mediated activation of human basophils in patients with food anaphylaxis dependent on and independent of nonsteroidal anti‐inflammatory drugs (2016) (25)
Chylothorax and tuberculosis. (1983) (25)
Muscle atrophy in severe exacerbation of asthma requiring mechanical ventilation. (1988) (24)
Relaciones entre rinosinusitis y bronquiectasias (2006) (24)
Inhibition of GM-CSF secretion by topical corticosteroids and nedocromil sodium. A comparison study using nasal polyp epithelial cells. (2000) (24)
Expression of glucocorticoid receptors alpha and beta in steroid sensitive and steroid insensitive interstitial lung diseases. (2004) (24)
Disminuye la incidencia de asma de riesgo vital en España (2006) (24)
Cut-off points for defining asthma control in three versions of the Asthma Control Questionnaire (2010) (23)
Reconstituted Human Upper Airway Epithelium as 3-D In Vitro Model for Nasal Polyposis (2014) (23)
Nonallergic Asthma and Its Severity: Biomarkers for Its Discrimination in Peripheral Samples (2018) (23)
Prevalence of aspirin intolerance in asthmatics treated in a hospital. (1986) (22)
Differential Expression of Remodeling Markers by Tissue Structure in Nasal Polyposis (2013) (22)
Simultaneous reversed-phase extraction of lipoxygenase and cyclooxygenase metabolites of arachidonic acid in nasal secretions: methodological aspects. (1990) (21)
Immunocytologic analysis of nasal cells obtained by nasal lavage: a comparative study with a standard method of cell identification (1993) (21)
Respiratory, ocular and skin health in recreational and competitive swimmers: Beneficial effect of a new method to reduce chlorine oxidant derivatives (2017) (21)
Effect of negative pressure ventilation on arterial blood gas pressures and inspiratory muscle strength during an exacerbation of chronic obstructive lung disease. (1991) (21)
Satisfacción y preferencia del paciente asmático por los dispositivos de inhalación. Aplicación del FSI-10 (2008) (21)
The Adaptor 3BP2 Is Required for Early and Late Events in FcεRI Signaling in Human Mast Cells (2012) (21)
Barcelona's asthma epidemics: clinical aspects and intriguing findings. (1992) (21)
Nasal and bronchial response to exercise in patients with asthma and rhinitis: the role of nitric oxide (2005) (21)
DETERMINACIÓN DE LAS PRESIONES RESPIRATORIAS ESTÁTICAS MÁXIMAS. PROPUESTA DE PROCEDIMIENTO (1990) (20)
Regulation of ICAM‐3 and other adhesion molecule expressions on eosinophils in vitro. Effects of dexamethasone (1999) (20)
Regulation of ICAM‐3 and other adhesion molecule expressions on eosinophils in vitro. Effects of dexamethasone (1999) (20)
Quantification of major urinary metabolites of PGE2 and PGD2 in cystic fibrosis: correlation with disease severity. (2013) (20)
Mometasone and desloratadine additive effect on eosinophil survival and cytokine secretion from epithelial cells (2011) (19)
Vasoactive intestinal peptide (VIP) induces IL-6 and IL-8, but not G-CSF and GM-CSF release from a human bronchial epithelial cell line (1997) (19)
Follow-up of patients with uncontrolled asthma: clinical features of asthma patients according to the level of control achieved (the COAS study) (2017) (19)
Control of Ventilation, Breathlessness Perception and Alexithymia in Near-Fatal Asthma (2006) (19)
Arnold-Chiari malformation and paralysis of the diaphragm. (1988) (19)
Proinflammatory cytokines and eosinophil cationic protein on glandular secretion from human nasal mucosa: regulation by corticosteroids. (2001) (19)
Biological agents: new drugs, old problems. (2010) (19)
Safety of triflusal (antiplatelet drug) in patients with aspirin‐exacerbated respiratory diseases (2007) (19)
Effects of topical glucocorticoids on in vitro lactoferrin glandular secretion: comparison between human upper and lower airways. (2000) (18)
The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival (2015) (18)
Multiple myeloma with pleural involvement. (1974) (18)
[Use of the mouse to unravel allergic asthma: a review of the pathogenesis of allergic asthma in mouse models and its similarity to the condition in humans]. (2005) (18)
Ototoxic reaction to erythromycin. (1991) (17)
Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design (2013) (17)
Proteasome Inhibition Reduces Proliferation, Collagen Expression, and Inflammatory Cytokine Production in Nasal Mucosa and Polyp Fibroblasts (2012) (17)
Integrated mRNA and microRNA transcriptome profiling during differentiation of human nasal polyp epithelium reveals an altered ciliogenesis (2020) (17)
Sputum sol phase proteins and elastase activity in patients with clinically stable bronchiectasis. (1992) (17)
Platelet-activating Factor Nasal Challenge Induces Nasal Congestion and Reduces Nasal Volume in Both Healthy Volunteers and Allergic Rhinitis Patients (2013) (17)
An intranasal selective antisense oligonucleotide impairs lung cyclooxygenase-2 production and improves inflammation, but worsens airway function, in house dust mite sensitive mice (2008) (16)
[Relation between rhinosinusitis and bronchiectasis]. (2006) (16)
Psychological profile of patients with bronchial asthma and functional dyspnea: a comparison with a non-asthmatic population and impact on the disease. (2011) (16)
Assessing biomarkers in a real-world severe asthma study (ARIETTA). (2016) (16)
Manifestaciones pulmonares de las enfermedades inflamatorias intestinales (2005) (16)
Características clínicas de las crisis de asma de riesgo vital en los pacientes sensibilizados a Alternaria alternata (2003) (16)
Early and late‐phase asthmatic reactions: a hypothesis (1992) (15)
Perfil psicológico de los pacientes con asma bronquial y disnea funcional: comparación con población no asmática e impacto sobre la enfermedad (2011) (15)
Asthmatic reaction induced by celecoxib in a patient with aspirin-induced asthma. (2009) (15)
Accuracy of acoustic rhinometry versus computed tomography in the evaluation of nasal cavity in patients with nasal polyposis. (2010) (15)
Efficacy and safety of dupilumab in patients with uncontrolled severe chronic rhinosinusitis with nasal polyps and a clinical diagnosis of NSAID‐ERD: Results from two randomized placebo‐controlled phase 3 trials (2021) (14)
[Cyclooxigenase-2 levels are increased in the lung tissue and bronchial tumors of patients with chronic obstructive pulmonary disease]. (2011) (14)
BAL lymphocyte activation antigens and diffusing capacity are related in mild to moderate pulmonary sarcoidosis. (1993) (14)
Altered expression and signalling of EP2 receptor in nasal polyps of AERD patients: role in inflammation and remodelling. (2017) (14)
Bronchoalveolar lavage cell analysis in patients with human immunodeficiency virus related diseases. (1989) (14)
[A cyclooxygenase-2 selective inhibitor worsens respiratory function and enhances mast cell activity in ovalbumin-sensitized mice]. (2009) (13)
Locally administered prostaglandin E2 prevents aeroallergen-induced airway sensitization in mice through immunomodulatory mechanisms. (2013) (13)
A Review of its Pharmacological Properties and Clinical Efficacy in the Treatment of Allergic Disorders (1996) (13)
Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study. (2009) (13)
Identification of mast cells in bronchoalveolar lavage fluid (1991) (13)
[Clinical characteristics of the fatal and near-fatal asthma in Alternaria alternata sensitized patients]. (2003) (13)
[Management according to the Global Initiative for Asthma guidelines of patients with near-fatal asthma reduces morbidity and mortality]. (2008) (13)
A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis. (2010) (13)
Cell content and albumin concentration in nasal lavage from patients with rhinitis. (1993) (13)
Release of chemical mediators and inflammatory cell influx during early allergic reaction in the nose: effect of furosemide. (1993) (13)
Discriminatory Molecular Biomarkers of Allergic and Nonallergic Asthma and Its Severity (2019) (12)
Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study. (1993) (12)
[Inflammatory response of rapid onset asthma exacerbation]. (2010) (12)
La ciclooxigenasa-2 está regulada al alza en el pulmón y en los tumores bronquiales de pacientes con enfermedad pulmonar obstructiva crónica (2011) (12)
COX‐1 sparing drugs in aspirin‐sensitive asthma (2001) (12)
PGE2 and PGF2α in the nasal lavage fluid from healthy subjects: Methodological aspects (1988) (12)
Lower sensitivity of nasal polyp fibroblasts to glucocorticoid anti-proliferative effects. (2011) (12)
Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo (2009) (12)
[Is the incidence of near-fatal asthma decreasing in Spain?]. (2006) (12)
Increased body mass index does not lead to a worsening of asthma control in a large adult asthmatic population in Spain. (2010) (12)
Prospective, single-arm, longitudinal study of biomarkers in real-world patients with severe asthma. (2020) (12)
[Skill in the handling of aerosols by health care personnel]. (1991) (11)
Acetylsalicylic Acid Prevents Intermittent Hypoxia-Induced Vascular Remodeling in a Murine Model of Sleep Apnea (2018) (11)
Retrosternal goiter and chylothorax: case report. (1986) (11)
Óxido nítrico nasal (2004) (11)
Superior effect of MP-AzeFlu than azelastine or fluticasone propionate alone on reducing inflammatory markers (2018) (11)
The Role of Cyclooxygenase in Acetylsalicylic Acid Sensitivity (2006) (11)
Signal Transduction Pathways (MAPKs, NF-κB, and C/EBP) Regulating COX-2 Expression in Nasal Fibroblasts from Asthma Patients with Aspirin Intolerance (2012) (11)
Un inhibidor selectivo de la ciclooxigenasa-2 empeora la función respiratoria y fomenta la actividad de los mastocitos en ratones sensibilizados a la ovalbúmina (2009) (10)
Profile of patients treated with omalizumab in routine clinical practice in Spain. (2014) (10)
Demonstration of surface antigens on bronchoalveolar lavage cells using the immunoalkaline phosphatase method. (1989) (10)
THE NOSE IN ASPIRIN-SENSITIVE ASTHMA (1998) (10)
Respuesta inflamatoria de la exacerbación asmática de instauración rápida (2010) (10)
Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study). (2017) (10)
Effects of Obesity and Asthma on Lung Function and Airway Dysanapsis in Adults and Children (2020) (10)
Usefulness of montelukast to prevent adverse reactions to COX-2 selective inhibitors: a case report. (2005) (10)
Effect of Lipopolysaccharide on Glucocorticoid Receptor Function in Control Nasal Mucosa Fibroblasts and in Fibroblasts from Patients with Chronic Rhinosinusitis with Nasal Polyps and Asthma (2015) (10)
[Nasal nitric oxide]. (2004) (10)
Evaluation of CD30 as a marker for th2 lymphocytes in bronchoalveolar lavage in interstitial lung diseases. (2000) (10)
Incidence and Characteristics of Asthma Exacerbations in Barcelona (ASMAB II) (2009) (10)
Celecoxib en pacientes con reacciones adversas cutáneas y respiratorias a los antiinflamatorios no esteroideos (2003) (9)
Antileukotrienes in rhinosinusitis and nasal polyposis (2008) (9)
Asthma, rhinitis, and nasal polyp multimorbidities. (2019) (9)
The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up. (2018) (9)
[Chylothorax as the initial manifestation of Waldenström's macroglobulinemia]. (1987) (9)
Segmental Contour Pattern in a Case of Pulmonary Venoocclusive Disease (1993) (9)
Occupational asthma and rhinoconjunctivitis caused by cricket allergy. (2008) (8)
Estudio piloto de los conocimientos sobre el asma y su tratamiento entre los educadores españoles (2001) (8)
Factores asociados con el asma grave no controlada y con la percepción del control por parte de médicos y pacientes (2014) (8)
Acoustic Rhinometry and Aspirin Nasal Challenge in the Diagnosis of Aspirin-Intolerant Asthma: Clinical Finding and Safety Aspects (2012) (8)
Deficient glucocorticoid induction of anti-inflammatory genes in nasal polyp fibroblasts of asthmatic patients with and without aspirin intolerance. (2013) (8)
Desensitization to clopidogrel: a growing need (2010) (8)
Inflammatory Response of Rapid Onset Asthma Exacerbation (2010) (8)
Prostaglandin E2 decreases basophil activation in patients with food‐induced anaphylaxis (2020) (8)
[Celecoxib in NSAID-induced cutaneous and respiratory adverse reactions]. (2003) (8)
[Eosinophil activation by epithelial cells of the respiratory mucosa. Comparative study of normal mucosa and inflammatory mucosa]. (1997) (8)
Psychological profile of patients with bronchial asthma and functional dyspnea: a comparison with a non-asthmatic population and impact on the disease (2011) (8)
Application of totally automated on-line sample clean up system for extraction and high-performance liquid chromatography separation of peptide leukotrienes. (1993) (8)
Factors Associated With Severe Uncontrolled Asthma and the Perception of Control by Physicians and Patients (2014) (7)
Release of peptide leukotrienes into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatics. (1991) (7)
Postcoital severe exacerbation of asthma requiring mechanical ventilation. (1987) (7)
Factors associated with severe uncontrolled asthma and the perception of control by physicians and patients. (2014) (7)
Food‐dependent NSAID‐induced hypersensitivity (FDNIH) reactions: Unraveling the clinical features and risk factors (2020) (7)
15-Hydroxyeicosatetraenoic acid as a major eicosanoid in nasal secretions: assay by high-performance liquid chromatographic-radioimmunoassay and gas chromatographic-mass spectrometric procedures. (1989) (7)
Failure of frusemide to increase production of prostaglandin E2 in human nasal mucosa in vivo. (1993) (7)
In Vitro and In Vivo Validation of EP2-Receptor Agonism to Selectively Achieve Inhibition of Mast Cell Activity (2020) (7)
Ability of asthmatics with and without respiratory arrest to detect added resistive loads. (1988) (7)
Clinical and inflammatory characteristics of patients with asthma in the Spanish MEGA project cohort (2021) (7)
Topical glucocorticoids downregulate COX‐1 positive cells in nasal polyps (2009) (7)
Specific immune response to Phleum pratense plant profilin in atopic patients and control subjects. (2001) (7)
Fluticasone Furoate Inhibits Cytokine Secretion from Nasal Epithelial Cells and Reduces Eosinophil Survival in an in vitro Model of Eosinophilic Inflammation (2014) (7)
Asthma, Rhinitis, and Nasal Polyp Multimorbidities (2019) (7)
Incidencia y caractersticas de las agudizaciones asmticas en Barcelona (ASMAB II) (2009) (6)
Safety of Parecoxib in Asthmatic Patients with Aspirin-Exacerbated Respiratory Disease (2011) (6)
Mecanismos de acción de los glucocortícoides. Aplicación al tratamiento de la inflamación respiratoria (1996) (6)
IL-4/IFN-γ inflammatory cytokine profile induces a deficient regulation of the IL-1β/IL-1RI/EP2/COX-2 pathway in nasal mucosa. (2019) (6)
Novel diagnostic approaches and biological therapeutics for intrinsic asthma (2014) (6)
Self-perception of olfactory dysfunction is associated with history of Traumatic Brain Injury: post-hoc analysis from the OLFACAT survey. (2019) (6)
Effects on nasal nitric oxide production of 2 mechanisms of vasoconstriction. (2007) (5)
P167: Epidemiologic Study of Smell in the Catalan Population (2006) (5)
Translocación nuclear del receptor de glucocorticoides en fibroblastos de pacientes asmáticos con poliposis nasal insensible al tratamiento glucocorticoideo (2011) (5)
The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up (2018) (5)
Presion inspiratoria maxima estatica (PIM). Relacion entre las presiones pico-meseta y efecto del aprendizaje (1987) (5)
Specific immune response to Parietaria judaica plant profilin: a low T cell proliferative response supports high IgE and skin prick test. (2002) (5)
[Response to glucocorticoid treatment in asthma. The role of alpha and beta isoforms of the glucocorticoid receptor]. (2002) (5)
Un modelo más de asma… pero un modelo útil (2009) (5)
Role of the Cyclooxygenase Pathway in the Association of Obstructive Sleep Apnea and Cancer (2020) (5)
[Anxiety crisis (panic attack) secondary to the administration of theophylline in an oral sustained-release preparation]. (1988) (4)
[Hypersensitivity pneumonitis after exposure to Candida spp]. (2010) (4)
Etiología de los quilotórax de origen no traumático (1985) (4)
Response of nose and bronchi to exercise in asthma and rhinitis: similarities and differences (1996) (4)
Estudio de los mecanismos implicados en la génesis y evolución del asma (proyecto MEGA): creación y seguimiento a largo plazo de una cohorte de pacientes asmáticos (2018) (4)
[MASK (Mobile Airways Sentinel Network). ARIA's comprehensive solution for mobile app for the multimorbidity of allergic rhinitis and asthma]. (2019) (4)
Trombosis crónica de la arteria pulmonar: descripción de un caso (1991) (4)
Prostaglandin PGE2 and PGF2alpha levels in nasal secretions from healthy subjects by liquid chromatography and radioimmunological assay. (1988) (4)
Nasal Polyposis: A Model of Chronic Airways Inflammation (2009) (4)
Respuesta al tratamiento glucocorticoideo en el asma. Papel de las isoformas α y β del receptor glucocorticoideo (2002) (4)
Impact of cell culture methods on the outcomes of the in vitro inflammatory response in nasal polyps. (2011) (4)
Spectrum of Disease Manifestations in Patients with Selective Immunoglobulin E Deficiency (2021) (4)
MASK (Mobile Airways Sentinel Network). La solución integral de ARIA por app móvil para la multimorbilidad de rinitis alérgica y asma (2019) (4)
Differences in Inflammatory Cytokine Profile in Obesity-Associated Asthma: Effects of Weight Loss (2022) (4)
[Q fever. Apropos of 13 case reports]. (1983) (4)
Prolonged fever in patients treated for tuberculosis. (1981) (4)
[Significance of the presence of mastocytes in bronchoalveolar lavage in the diagnostic evaluation of diffuse interstitial lung diseases]. (1989) (4)
Again an asthma model... but a useful one (2009) (4)
Eicosanoid dysregulation and type 2 inflammation in AERD. (2021) (4)
Non‐steroidal anti‐inflammatory drugs‐induced urticaria and angioedema: more research on mechanisms needed (2005) (4)
Asthma, rhinitis and eczema symptoms in Quito, Ecuador: a comparative cross-sectional study 16 years after ISAAC (2021) (4)
Neumonitis por hipersensibilidad tras exposición a Candida spp (2010) (3)
PGE2 and PGF2 alpha in the nasal lavage fluid from healthy subjects: methodological aspects. (1988) (3)
Impact of Nasal Polyposis and Its Medical or Surgical Treatment on Quality of Life (2004) (3)
Grado de conocimiento de las propias sensibilizaciones alérgicas en pacientes asmáticos y su repercusión en el nivel de control del asma (2013) (3)
Exacerbations among patients with asthma are largely dependent on the presence of multimorbidity. (2022) (3)
Knowledge of their own allergic sensitizations in asthmatic patients and its impact on the level of asthma control. (2013) (3)
Nasal polyps, aspirin sensitivity, and late onset asthma are crucial to identify severe asthma. clinicaltrials.gov id : nct01513837 (2015) (3)
Early lung function changes after short heavy exposure to chrysotile asbestos in non-smoking women. (1986) (3)
In Vitro Evidence Of The Synergistic Effect Of Non Steroidal Anti Inflammatory Drugs (NSAIDs) Into Ig-E Mediated Food Allergy Response In Basophils (2011) (3)
[Assessment of the simplified versions of the Asthma Control Questionnaire]. (2008) (3)
MP29-02* reduces eosinophil survival induced by epithelial cell secretions from nasal mucosa (2015) (3)
Faculty Opinions recommendation of Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. (2007) (3)
Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study). (2017) (3)
Asthma: A New Cardiovascular Risk Factor? (2019) (3)
Aspirin Sensitivity as a Clinical Marker for Severe Asthma and United Airway Disease (2014) (3)
Neumonia eosinofila cronica. revision de 12 casos (1986) (3)
Precise diagnosis of airflow obstruction--does it matter for treatment? SEPCR Workshop, Wiesbaden 1989. (1990) (3)
Desensitization in aspirin-sensitive asthmatics. (1986) (2)
Effects Of Rupatadine On Platelet Activating Factor (PAF)-induced Human Mast Cell Degranulation Compared With Desloratadine And Levocetirizine (2012) (2)
Recovery of nasal prostaglandin production after inhibition by aspirin. (1990) (2)
Efficacy/risk profile of triamcinolone acetonide in severe asthma: Lessons from one case study (2008) (2)
[Catecholamine secreting tumors (pheochromocytoma and ganglioneuroma) associated with neurofibromatosis]. (1973) (2)
Diagnosis of asbestosis (2007) (2)
Nuclear translocation of the glucocorticoid receptor in fibroblasts of asthmatic patients with nasal polyposis insensitive to glucocorticoid treatment. (2011) (2)
Evaluación de las versiones simplificadas del Cuestionario de Control del Asma (2008) (2)
Asma de manejo dificil (1986) (2)
PAA2 PREVALENCE OF UNCONTROLLED SEVERE PERSISTENT ASTHMA PATIENTS IN PNEUMOLOGY AND ALLERGY HOSPITAL UNITS IN SPAIN (2007) (2)
Presion de oclusion. Formas de medicion (1987) (2)
[Diagnosis of pneumonia caused by Pneumocystis carinii using induced sputum]. (1990) (2)
Betaagonistas y su influencia en la morbimortalidad por asma. Un problema tipo guadiana (1992) (2)
Rinitis, poliposis nasal y su relación con el asma (2019) (2)
[Characteristics and evolution of uremic pleural effusion]. (1988) (2)
Los neumólogos y la nariz (1995) (2)
Fatty Acid Composition of Cultured Fibroblasts Derived from Healthy Nasal Mucosa and Nasal Polyps (2016) (2)
Prevalence of Atopy to Common Aeroallergens and Moulds in Patients with Nasal Polyposis (2004) (2)
Platelet kinetics in asthmatic patients with and without aspirin intolerance. (1992) (2)
[Tracheobronchomegaly associated with bronchiectasis]. (1987) (2)
[Clinicopathological study of 23 pleural malignant mesotheliomas]. (1988) (2)
Asthma with nasal polyps: The “severe” phenotype? ClinicalTrials.gov ID: NCT01513837 (2014) (2)
[Prevalence of allergic bronchopulmonary aspergillosis]. (1987) (2)
FORMA CRÓNICA DE LA NEUMONÍA INTERSTICIAL POR NITROFURANTOINA (1984) (1)
Overnight Change in Urinary Prostacyclin and Thromboxane in Obstructive Sleep Apnea. (2019) (1)
[Anterior rhinomanometry]. (1990) (1)
Selective IgE deficiency predicts poor or no response of chronic spontaneous urticaria to omalizumab. (2022) (1)
Nuclear Translocation of the Glucocorticoid Receptor in Fibroblasts of Asthmatic Patients with Nasal Polyposis Insensitive to Glucocorticoid Treatment (2011) (1)
IgE plasma level in asthmatics with nasal polyps is independent of atopy (2016) (1)
The Contribution of ISAAC to the Understanding of Asthma (2009) (1)
Dysfunctional Breathing Associated With Asthma. Psychological Profile Differences Between Asthmatics And Non Asthmatic People (2010) (1)
The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma (2017) (1)
Severe acute asthma or acute severe asthma? (1983) (1)
Acetónido de triamcinolona en el tratamiento del asma resistente a los glucocorticoides: riesgos y beneficios (2008) (1)
Neuropéptidos. Su papel en la fisiopatología respiratoria humana (1993) (1)
Change of Title: Sinusitis Becomes Sinusitis and Asthma (2018) (1)
Asma: ¿un nuevo factor de riesgo cardiovascular? (2019) (1)
Altered expression and signalling of EP2 receptor in nasal polyps of AERD patients: role in inflammation and remodelling (2016) (1)
2 LEN guideline : aspirin provocation tests for diagnosis of aspirin hypersensitivity (2007) (1)
Acropaquia: valoracion objetiva y subjetiva en trabajadores del asbesto (1980) (1)
Status asthmaticus, severe acute asthma or severe exacerbation of asthma. (1985) (1)
[Incidence and characteristics of asthma exacerbations in Barcelona (ASMAB II)]. (2009) (1)
Weight loss and vitamin D improve hyporesponsiveness to corticosteroids in obese asthma. (2022) (1)
Pulmonary involvement inprimary biliary cirrhosis (1981) (1)
Effect of naloxone on arterial gases in chronically obstructed patients with acute respiratory failure. (1985) (1)
Knowledge and perceptions of asthma in Zambia: A preliminary report (2012) (1)
Smell improvement by anti-IgE and anti-IL 5 biologics in patients with CRSwNP and severe asthma. A real life study. (2021) (1)
Patologías mediadas por la inmunoglobulina E: de la inmunoglobulina E al omalizumab (2012) (1)
Distinct transcriptome profiles differentiate NSAID-dependent from NSAID-independent food anaphylaxis (2016) (1)
Loss of smell: a clinical marker of severe asthma (2018) (1)
[Mechanisms of action of glucocorticoids. Application to the treatment of respiratory inflammation]. (1996) (1)
Psychological Profile Of Asthmatic Patients With Dysfunctional Breathing And Its Impact On Asthma Outcome (2010) (1)
[Immunotherapy in bronchial asthma: reality or fiction]. (1984) (1)
Hypersensitivity Pneumonitis after Exposure to Candida spp (2010) (1)
[Anxiety attacks provoked by theophylline]. (1987) (1)
The Arietta Study: Exploring Severe Asthma Biomarkers in a Real-World Setting (2016) (1)
[Thoracic actinomycosis. Presentation of 3 cases]. (1993) (1)
Reference Gene Validation for RT–qPCR in PBMCs from Asthmatic Patients with or without Obesity (2022) (1)
Inflammation in cystic fibrosis patients: study of the eicosanoid pathway and severity correlations (2021) (1)
[Familial diffuse interstitial pulmonary fibrosis]. (1983) (1)
Anxiety and BMI affect asthma control: data from a prospective Spanish cohort. (2021) (1)
[Acute myopathy related to the administration of glucocorticoids and neuromuscular blockers]. (1994) (1)
Treatment of Aspirin-Sensitive Asthma with Aspirin (1985) (1)
Overnight Change in Urinary Prostacyclin and Thromboxane in Obstructive Sleep Apnea (2019) (1)
Discussion Session A: The early life origins of asthma (1998) (1)
[Inadequate antidiuretic hormone secretion syndrome associated with acute pneumonia. Considerations on diagnostic methods]. (1985) (1)
Myofibroblast Cell Transition Induced By TGF-b1 Implies An Altered Arachidonic Acid Metabolism In Human Lung (2010) (1)
[Anaplastic small cell carcinoma of the lung as a cause of acquired stenosis of the pulmonary artery. Pulmonary emboli as initial manifestations]. (1982) (1)
Correction: The Adaptor 3BP2 Is Required for KIT Receptor Expression and Human Mast Cell Survival (2018) (0)
Asthma and severe obesity: glucocorticoid sensitivity before and after bariatric surgery (2019) (0)
Obese Asthma Syndrome: Much Work to Do. (2023) (0)
Risk factors associated with poor asthma control and quality of life in severe Spanish asthmatics (2011) (0)
ions on nasal epithelium by steroids as shown in this study would contribute to the alleviation of the clinical symptoms by way of suppressing the hypersecretion of the patients suffering from allergic rhinitis (2004) (0)
Prevalence and associated factors for asthma in adults in Quito: a cross-sectional study (2022) (0)
Endothelin and the Airway Epithelium (1999) (0)
Total and free IgE in evolution of severe asthma after omalizumab treatment (2016) (0)
Faculty Opinions recommendation of Functional impact of pulmonary hypertension due to hypoventilation and changes under noninvasive ventilation. (2013) (0)
Agreement between asthma control perception by patients, by physicians and according to guidelines (2011) (0)
Prevalence and associated factors for asthma in adults in Quito: a cross-sectional study Prevalencia y factores asociados para asma en adultos en Quito: un estudio transversal (2022) (0)
Evaluation of second generation antihistamines following a 2 or 4-weeks treatment by means of a pooled responder analysis in patients suffering from seasonal allergic rhinitis (2008) (0)
Receptor Signaling in Human Mast Cells CD84 Negatively Regulates IgE High-Affinity (2011) (0)
ABS75: Asthma treatment in Spain — Study in primary care and Pneumology Services (2006) (0)
Abstracts from the 11th Symposium on Experimental Rhinology and Immunology of the Nose (SERIN 2017) (2017) (0)
AAAAI ARIETTA study design poster for DGP (2016) (0)
132 Characterization of 2 Epithelial Cell Air-Liquid Interface (ALI) Culture Models for Human Healthy Nasal Mucosa and Nasal Polyps (2012) (0)
Faculty Opinions recommendation of Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology. (2012) (0)
Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis. (2022) (0)
Aspirin-Induced Asthma: What We Know Now (2004) (0)
The Effect of Corticosteroids in Patients with Nasal Polyposis and Asthma (2004) (0)
RI Signaling in Human ε Late Events in Fc The Adaptor 3BP2 Is Required for Early and (2012) (0)
133 Corticosteroid Rreatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps (2012) (0)
Lipid transfer protein: a link between food and respiratory allergy (2013) (0)
asthma . subjects and in patients with rhinitis and Response of the nose to exercise in healthy (2004) (0)
Effects ofafish oilenriched diet onaspirin intolerant asthmatic patients: apilot study (2011) (0)
Faculty Opinions recommendation of Intratracheal transplantation of alveolar type II cells reverses bleomycin-induced lung fibrosis. (2008) (0)
219 Elevated prostaglandins urine levels is associated with disease severity in cystic fibrosis patients (2017) (0)
[Death from asthma. Analysis of 21 cases]. (1986) (0)
Rupatadine of its Use in the Management of Allergic Disorders (2007) (0)
Subject Index Vol. 149, 2009 (2009) (0)
Nasal challenge test in the diagnosis of latex-related systemic reactions. (2012) (0)
[Triamcinolone acetonide in the treatment of corticosteroid-resistant asthma: risks and benefits]. (2008) (0)
Glucocorticoids downregulate COX-1 positive cells in nasal polyps (2005) (0)
Prevalence and clinical relevance of low levels of Pru p 3 specific IgE in patients with peach sensitization (2013) (0)
Transgenic mice overexpressing the PGE2 receptor EP2 on mast cells exhibit a protective phenotype in a model of allergic asthma (2021) (0)
[Tuberculous lymphadenitis: a review of 50 cases]. (1983) (0)
[Asthma, aspirin, prostaglandins and leukotrienes]. (1986) (0)
Failure offrusemide toincrease production of prostaglandin E2inhumannasal mucosainvivo (1993) (0)
[Executive Summary of ARIA 2019: Integrated care pathways for allergic rhinitis in Argentina, Spain and Mexico]. (2019) (0)
Platelet activating factor-induced mast cell degranulation is inhibited by rupatadine, and to a lower extent by levocetirizine and desoratadine, in a mast cell line (LAD-2) (2013) (0)
Mice overexpressing the mast cell EP2 receptor exhibit a protective phenotype against House Dust Mite-induced airway alterations (2020) (0)
Prostaglandin E2: A Potential Link Between Cystic Fibrosis and Cancer. (2022) (0)
The creation and long-term follow-up of a cohort of asthmatic patients. Baseline clinical characteristics of the study population: The MEGA Project: (2017) (0)
S284 – Impact of Asthma and Atopy on Smell in Nasal Polyposis (2008) (0)
Accuracy of Acoustic Rhinometry Versus Computed Tomography in the Evaluation of Nasal Cavity in Patients with Nasal Polyposis (2008) (0)
Identification of Asthma Phenotypes in the Spanish MEGA Cohort Study Using Cluster Analysis. (2023) (0)
[Again an asthma model... but a useful one]. (2009) (0)
Cigarette smoking is decresed in severe asthma and associated with chronic rhinosinusitis without nasal polyps (2019) (0)
Aspirin Desensitization in NERD in the Era of Biologics: First or Last Resource? (2022) (0)
Gene Expression Profiling Of Food-Induced Anaphylaxis Associated With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) (2014) (0)
Faculty Opinions recommendation of A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma. (2010) (0)
double blind, randomised, comparative trial asthma exacerbation in adults: one year, against salmeterol and fluticasone in protecting Montelukast and fluticasone compared with (2005) (0)
Relevance of food allergy in the assessment of NSAID-involved reactions (2015) (0)
How reliably can algorithms identify eosinophilic asthma phenotypes using non‐invasive biomarkers? (2022) (0)
Mometasone and Desloratadine Have an Additive Effect on Eosinophil Survival Induced by Epithelial Cells Culture Supernatants from Nasal Mucosa and Polyps (2008) (0)
Desloratadine inhibits GM-CSF secretion from nasal mucosa and polyps and eosinophil survival induced by epithelial cells (2004) (0)
RENTABILIDAD DEL ESTUDIO ESPIROMETRICO PREOPERATORIO (1982) (0)
Omalizumab (Xolair®) in Severe Uncontrolled Asthma: Two-Year Clinical Experience. (2009) (0)
Prevalencia y determinantes de asma en adultos en Quito: un estudio transversal (2022) (0)
Linfocitosis en el lavado broncoalveolar de la linfangitis carcinomatosa (1987) (0)
Role of cyclooxygenase 1 and 2 in asthma and rhinitis. (1997) (0)
Interrelación entre asma y alergia digestiva (2013) (0)
Tromboembolismo pulmonar en el lupus eritematoso sistemico (1986) (0)
La leyenda de la virgen de La Calle: aproximación desde la hermeneútica antropología (1995) (0)
El tiempo y más allá del tiempo. Las coplas de Jorge Manrique una vez más (2016) (0)
Brujas en Palencia. De la creencia popular a la recreación literaria. (2019) (0)
Sarcoidosis: manifestaciones radiologicas pulmonares infrecuentes (1988) (0)
Faculty Opinions recommendation of Response to add-on inhaled corticosteroids in COPD based on airway hyperresponsiveness to mannitol. (2012) (0)
Aranda decimonónica en el espejo de la literatura (2006) (0)
MASK (Mobile Airways Sentinel Network), una app móvil con la solución integral de ARIA en países de habla hispana (2019) (0)
Manejo terapéutico a largo plazo del asma (2001) (0)
An Unusual Combination of Diffuse Pulmonary Cysts and a Nodule (2020) (0)
Resumen ejecutivo de ARIA 2019: Vías integradas de atención para la rinitis alérgica en Argentina, España y México. (2019) (0)
ENFERMEDAD PULMONAR INTERSTICIAL EN LA DERMATOMIOSITIS (1986) (0)
COX-1 AND COX-2 ARE UP-REGULATED IN NASAL POLYPS IN CYSTIC FIBROSIS (2006) (0)
SurvivalReceptor Expression and Human Mast Cell The Adaptor 3BP2 Is Required for KIT (2015) (0)
Calcificaciones pleurales diafragmaticas en un minero catalan del asbesto (1982) (0)
Fe de errores de Implicación de la alteración en la regulación de la ciclooxigenasa-2 sobre la formación de miofibroblastos en la fibrogénesis pulmonar (2009) (0)
Ritos, conocimientos y creencias en el Cerrato palentino (2001) (0)
[Pneumologists and the nose]. (1995) (0)
DIAGNOSTICO DE LA MICROLITIASIS ALVEOLAR MEDIANTE BIOPSIA PULMONAR TRANSBRONQUIAL (1988) (0)
Pleuropericarditis eosinofílica como manifestación inicial de la enfermedad de Hodgkin (1987) (0)
Severe alcoholism and asbestos exposure: report of two cases. (1983) (0)
[Asthma and platelets]. (1988) (0)
Fluticasone Furoate Decreases Nasal Eosinophilic Inflammation by Inhibiting Both Cytokine Secretion From Nasal Mucosa Epithelial Cells Cytokine Secretion and Eosinophil Survival (2013) (0)
[Spontaneous hemopneumothorax]. (1970) (0)
Contents Vol. 149, 2009 (2009) (0)
NHLBI-CNR workshop on 'usefulness and perspectives of bronchoalveolar lavage', Parma, June 13-14, 1988. (1989) (0)
AUTHORS' REPLY (1992) (0)
[Pleural amyloidosis]. (1987) (0)
Skin Manifestations in Patients with Selective Immunoglobulin E Deficiency (2022) (0)
[MASK (Mobile Airways Sentinel Network), a mobile App with ARIA's comprehensive solution in Spanish-speaking countries]. (2019) (0)
174 Quantification of major urinary metabolite of PGE2 in cystic fibrosis (CF) patients: Correlation with parameters of disease severity (2013) (0)
[Prolonged febrile syndrome caused by pelvic abscess in a patient with systemic lupus erythematosus]. (1990) (0)
Therapeutic implications of a precise diagnosis of airflow obstruction. (1990) (0)
[Atmospheric pollution and bronchial asthma]. (1984) (0)
Eosinophilic sialodochitis: a rare comorbidity of severe asthma. (2022) (0)
[Tuberculosis. Persistence of the febrile syndrome despite correct tuberculostatic treatment]. (1982) (0)
[Etiology of chylothorax of non-traumatic origin]. (1986) (0)
Early results of hips replacement co-10 (1994) (0)
Faculty Opinions recommendation of Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. (2014) (0)
[Pneumonia due to Mycoplasma pneumoniae. Clinicoradiological study of 28 cases (author's transl)]. (1981) (0)
[How do we use theophyllines?]. (1986) (0)
Characterization of two epithelial cell air-liquid interface (ALI) culture models for human healthy nasal mucosa and nasal polyps (2013) (0)
Lung function abnormalities and their correlation with clinical characteristics and inflammatory markers in adult asthma. (2022) (0)
[A 69-year-old female with extrapyramidal syndrome and pulmonary masses]. (1989) (0)
[A 76-year-old male with fever, cough and dyspnea]. (1984) (0)
Faculty Opinions recommendation of Acute pulmonary embolism: external validation of an integrated risk stratification model. (2013) (0)
Quality of diagnosis and assessment in primary care (2011) (0)
Howmany manoeuvres should bedonetomeasure maximal inspiratory mouthpressureinpatients with chronic airflow obstruction (2011) (0)
Subject Index, Vol. 56, 1989 (1989) (0)
PRS60 The Impact of Severe Poor-Controlled Asthma On Patients' Quality of Life Control Study (2011) (0)
AUTHOR'S REPLY (1992) (0)
[Corticoids in bronchial asthma. Not too little nor too much]. (1990) (0)
Efficacy and safety of one-puff, once-daily, evening treatment with mometasone furoate dry-powder inhaler 400 mcg compared with fluticasone propionate metered dose inhaler 125 mcg two puffs, twice daily in asthma patients switched from fluticasone propionate (2003) (0)
[Trapped lung syndrome. A rare cause of chronic pleural effusion]. (1985) (0)
Lipopolysacharide modulates glucocorticoid receptor function in nasal mucosa and polyp fibroblasts (2013) (0)
[Clinical trials in bronchial asthma]. (2000) (0)
[Association of allergic bronchopulmonary aspergillosis and mucoviscidosis]. (1985) (0)
[Bronchial asthma and bronchial hyperreactivity: friends for ever]. (1996) (0)
[Significance of the presence of herpes simplex virus in pulmonary pathology]. (1986) (0)
[A 16-year-old woman with pulmonary nodules]. (1990) (0)
Role o of b bronchoalveolar llavage iin tthe d diagnosis o of fat e embolism s syndrome (1995) (0)
[Eosinophils in the broncho-alveolar lavage of diffuse interstitial lung diseases]. (1985) (0)
Pulmonary involvement in primary biliary cirrhosis Table 2 Investigation of kertoconjunctivitis and xerostomia Cases Lacrimal (0)
[Lymphomatoid granulomatosis. Presentation of 3 cases]. (1986) (0)
[Pilot study on knowledge about asthma and its treatment among Spanish teachers]. (2001) (0)
[Pneumonias and plasma osmoregulation]. (1988) (0)
Evaluation of Nasal Patency and Nasal Nitric Oxide Levels in Subjects with Allergic Rhinitis After Pharmacologic or Physiologic Stimuli: a Two Parallel Groups Study (2006) (0)
Response ofthenosetoexercise inhealthy subjects andinpatients withrhinitis andasthma (1994) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With César Picado?

César Picado is affiliated with the following schools:

César Picado's Academic­Influence.com Rankings

César Picado's Degrees

Similar Degrees You Can Earn

Why Is César Picado Influential?

César Picado's Published Works

Published Works

What Schools Are Affiliated With César Picado?

César Picado's AcademicInfluence.com Rankings